Targeted co-delivery of curcumin and erlotinib by MoS2 nanosheets for the combination of synergetic chemotherapy and photothermal therapy of lung cancer

Targeted co-delivery of curcumin and erlotinib by MoS2 nanosheets for the combination of synergetic chemotherapy and photothermal therapy of lung cancer

Abstract Background Curcumin (Cur), a bioactive component of Chinese traditional medicine, has demonstrated inhibitory properties against cancer cell proliferation while synergistically enhancing the anticancer efficacy of erlotinib (Er). However, the individual limitations of both drugs, including...

Full description

Bibliographic Details
Main Authors: Zhihuai Chen, Xinqi Wei, Yunru Zheng, Zongwei Zhang, Wang Gu, Wenjun Liao, Hua Zhang, Xiaoying Wang, Jian Liu, Hua Li, Wei Xu
Format: Article
Language:English
Published: BMC 2023-09-01
Series:Journal of Nanobiotechnology
Subjects:
MoS2 nanosheets
Biotin
NIR light-responsive drug release
Synergistic chemotherapy
Photothermal therapy
Online Access:https://doi.org/10.1186/s12951-023-02099-4

Internet

https://doi.org/10.1186/s12951-023-02099-4

Similar Items